Maryland State Retirement & Pension System’s Neurocrine Biosciences NBIX Stock Holding History

Maryland State Retirement & Pension System’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$942K	Buy	5,591 +930	+20%	+$138K	0.02%	598
2026 Q1	$614K	Hold	4,661	–	–	0.01%	706
2025 Q4	$661K	Hold	4,661	–	–	0.01%	667
2025 Q3	$654K	Hold	4,661	–	–	0.01%	667
2025 Q2	$586K	Hold	4,661	–	–	0.01%	854
2025 Q1	$516K	Sell	4,661 -663	-12%	-$84K	0.01%	896
2024 Q4	$727K	Sell	5,324 -372	-7%	-$46K	0.02%	837
2024 Q3	$656K	Sell	5,696 -1,754	-24%	-$240K	0.01%	905
2024 Q2	$1.03M	Hold	7,450	–	–	0.02%	673
2024 Q1	$992K	Hold	7,450	–	–	0.02%	671
2023 Q4	$982K	Hold	7,450	–	–	0.02%	697
2023 Q3	$838K	Hold	7,450	–	–	0.02%	702
2023 Q2	$703K	Hold	7,450	–	–	0.01%	851
2023 Q1	$754K	Hold	7,450	–	–	0.02%	769
2022 Q4	$890K	Buy	+7,450	New	+$873K	0.03%	620
2022 Q3	–	Sell	-7,049	Closed	-$687K	–	920
2022 Q2	$687K	Hold	7,049	–	–	0.02%	727
2022 Q1	$661K	Hold	7,049	–	–	0.02%	847
2021 Q4	$600K	Hold	7,049	–	–	0.02%	968
2021 Q3	$672K	Hold	7,049	–	–	0.02%	881
2021 Q2	$687K	Hold	7,049	–	–	0.02%	611
2021 Q1	$686K	Buy	+7,049	New	+$739K	0.02%	607

Other funds holding NBIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Maryland State Retirement & Pension System's NBIX Position: Q2 2026 in Review

Maryland State Retirement & Pension System increased its Neurocrine Biosciences (NBIX) stake by 20% in Q2 2026, buying an estimated $138K and bringing the position to 5,591 shares worth $942K. The position accounts for 0.02% of the portfolio, ranked #598.

Maryland State Retirement & Pension System first reported a position in NBIX in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.03M in Q2 2024. 772 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

Maryland State Retirement & Pension System held 5,591 shares of Neurocrine Biosciences worth $942K as of Q2 2026.
Maryland State Retirement & Pension System bought 930 Neurocrine Biosciences shares in Q2 2026, an estimated $138K.
Neurocrine Biosciences made up 0.02% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #598 holding.
Maryland State Retirement & Pension System first reported a position in Neurocrine Biosciences in Q1 2021 and has held it in 21 quarters since.
Maryland State Retirement & Pension System's Neurocrine Biosciences position peaked at $1.03M in Q2 2024.
772 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.